The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $28.18

Today's change-0.54 -1.88%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.
 

Omega Healthcare Investors Inc

NYSE: OHI
Last

(U.S.) $28.18

Today's change-0.54 -1.88%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

Omega Healthcare Investors Inc down (U.S.)$0.54

Omega Healthcare Investors Inc closed sharply lower Friday, dropping (U.S.)$0.54 or 1.88% to (U.S.)$28.18. Over the last five days, shares have lost 10.96% and sit 4.51% above their 52-week low. This security has underperformed the S&P 500 by 20.00% during the last year.

Key company metrics

  • Open(U.S.) $29.00
  • Previous close(U.S.) $28.72
  • High(U.S.) $29.31
  • Low(U.S.) $28.13
  • Bid / Ask-- / --
  • YTD % change-19.44%
  • Volume1,618,435
  • Average volume (10-day)2,493,528
  • Average volume (1-month)1,847,261
  • Average volume (3-month)1,456,221
  • 52-week range(U.S.) $26.96 to (U.S.) $42.00
  • Beta0.84
  • Trailing P/E22.61×
  • P/E 1 year forward15.40×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.28
  • Dividend yield8.09%
  • Trailing EPS(U.S.) $1.25
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+31.38%

Based on its net profit margin of 31.38%, Omega Healthcare Investors Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue211202198133
Total other revenue--------
Total revenue211202198133
Gross profit--------
Total cost of revenue--------
Total operating expense867612347
Selling / general / administrative2010106
Research & development--------
Depreciation / amortization61605931
Interest expense (income), net operating--------
Unusual expense (income)555411
Other operating expenses, total--------
Operating income1251267486
Interest income (expense), net non-operating-41-40-40-34
Gain (loss) on sale of assets0-29--
Other--------
Income before tax64844443
Income after tax64834343
Income tax, total001--
Net income61794143
Total adjustments to net income--------
Net income before extra. items61794143
Minority interest-3-4-2--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items61794143
Inc. avail. to common incl. extra. items61794143
Diluted net income61794143
Dilution adjustment0000
Diluted weighted average shares198195194135
Diluted EPS excluding extraordinary itemsvalue per share0.310.410.210.32
Dividends per sharevalue per share0.560.550.180.89
Diluted normalized EPSvalue per share0.330.450.440.40